Crystal violet combined with Merocyanine 540 for the ex vivo purging of hematopoietic stem cell grafts

Journal of Photochemistry and Photobiology B: Biology

Volumn 70, Issue 3, 2003, Pages 133-144

  Miyagi, Kiyoko ^a   Sampson, Reynée W ^a   Sieber Blum, Maya ^a   Sieber, Fritz ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Autologous stem cell transplantation; Crystal violet; Lung cancer; Merocyanine 540; Multi drug resistance; Photochemotherapy; Purging

Indexed keywords

CD34 ANTIGEN; CISPLATIN; CRYSTAL VIOLET; DOXORUBICIN; MELPHALAN; MEROCYANINE; PHOTOSENSITIZING AGENT;

ANIMAL CELL; BONE MARROW PURGING; BREAST CANCER; CANCER CELL CULTURE; CELL MUTANT; CELL STRAIN HL 60; COLONY FORMING UNIT GM; CONTROLLED STUDY; DEPLETION; DRUG EFFICACY; DRUG EXPOSURE; DRUG SENSITIVITY; DRUG STRUCTURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; REDUCTION; REVIEW; SOLID TUMOR; STEM CELL; STRUCTURE ANALYSIS; TUMOR CELL; WILD TYPE;

VIOLA (ANGIOSPERM);

EID: 0141792990     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(03)00073-3     Document Type: Article

References (57)

1. J. Riley, Retardation of growth of a transplantable carcinoma in mice fed basic metachromatic dyes, Cancer Res. 8 (1948) 183-188.
2. M.R. Lewis, P.P. Goland, The tumor-inhibitory activity of diaryl-and triarylmethane dyes. I. The Ehrlich ascites mouse tumor, Cancer Res. 13 (1953) 130-136.
3. K. Wadwa, S. Smith, A.R. Oseroff, Cationic triarylmethane photosensitizers for selective photochemotherapy: Victoria Blue-BO, Victoria Blue-R and Malachite Green, SPIE 997 (1988) 154-160.
4. J. Patel, D. Rideout, K.S. Wadwa, A.R. Oseroff, Design of novel analogs of Victoria Blue BO (VBBO) for photodynamic therapy, Abstr. Am. Chem. Soc. 203 (1992) 37.
5. M. Wainwright, S.M. Burrow, S.G.R. Guinot, D.A. Phoenix, J. Waring, Uptake and cell-killing activities of a series of Victoria Blue derivatives in a mouse mammary tumour cell line, Cytotechnology 29 (1999) 35-43.
6. M. Fiedorowicz, J.R. Galindo, M. Julliard, P. Mannoni, M. Chanon, Efficient photodynamic action of Victoria Blue BO against the human leukemic cell lines K-562 and TF-1, Photochem. Photobiol. 58 (1993) 356-361.
7. G.L. Indig, G.S. Anderson, M.G. Nichols, J.A. Bartlett, W.S. Mellon, F. Sieber, Effect of molecular structure on the performance of triarylmethane dyes as therapeutic agents for photochemical purging of autologous bone marrow grafts from residual tumor cells, J. Pharm. Sci. 89 (2000) 88-99.
8. I. Tsujino. F. Sieber, unpublished, 1999.
9. I.C. Summerhayes, T.J. Lampidis, S.D. Bernal, J.J. Nadakavukaren, K.K. Nadakavukaren, E.L. Shepherd et al., Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells, Proc. Natl. Acad. Sci. USA 79 (1982) 5292-5296.
10. L.B. Chen, Mitochondrial membrane potential in living cells, Annu. Rev. Cell Biol. 4 (1988) 155-181.
11. A.R. Oseroff, D. Ohuoha, G. Ara, D. McAuliffe, J. Foley, L. Cincotta, Intramitochondrial dyes allow selective in vitro photolysis of carcinoma cells, Proc. Natl. Acad. Sci. USA 83 (1986) 9729-9733.
12. A.R. Oseroff, D. Ohuoha, G. Ara, C. Pastel-Levy, T. Flotte, L. Foley et al., Selective photochemotherapy of melanoma and human squamous carcinoma using cationic photosensitizers, J. Invest. Dermatol. 88 (1987) 510.
13. J.S. Modica-Napolitano, J.L. Joyal, G. Ara, A.R. Oseroff, J.R. Aprile, Mitochondrial toxicity of cationic photosensitizers for photochemotherapy, Cancer Res. 50 (1990) 7876-7881.
14. N. Krishnamachary, M.S. Center, The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein, Cancer Res. 53 (1993) 3658-3661.
15. K. Kasahara, Y. Fujiwara, K. Nishio, T. Ohmori, Y. Sugimoto, K. Komiya et al., Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin, Cancer Res. 51 (1991) 3237-3242.
16. S. Ahmad, L. Okine, B. Le, P. Najarian, D.T. Vistica, Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells, J. Biol. Chem. 262 (1987) 15048-15053.
17. F. Sieber, J.L. Spivak, A.M. Sutcliffe, Selective killing of leukemic cells by merocyanine 540-mediated photosensitization, Proc. Natl. Acad. Sci. USA 81 (1984) 7584-7587.
18. T. Itoh, H.A. Messner, N. Jamal, M. Tweeddale, F. Sieber, Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: Potential applications in autologous bone marrow transplantation, Bone Marrow Transplant. 12 (1993) 191-196.
19. N.N. Iscove, F. Sieber, K.H. Winterhalter, Erythroid colony formation in cultures of mouse and human bone marrow: Analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin A, J. Cell. Physiol. 83 (1974) 309-320.
20. F. Sieber, S. Rao, S.D. Rowley, M. Sieber-Blum, Dye-mediated photolysis of human neuroblastoma cells: Implications for autologous bone marrow transplantation, Blood 68 (1986) 32-36.
21. G.S. Anderson, I. Tsujino, K. Miyagi, R. Sampson, F. Sieber, Preferential inactivation of paediatric solid tumour cells by sequential exposure to Merocyanine 540-mediated photodynamic therapy and Edelfosine: Implications for the ex vivo purging of autologous haematopoietic stem cell grafts, J. Photochem. Photobiol. B: Biology 68 (2003) 87-95.
22. S.C. Chow, M. Weis, G.E. Kass, T.H. Holmstrom, J.E. Eriksson, S. Orrenius, Involvement of multiple proteases during Fas-mediated apoptosis in T lymphocytes, FEBS Lett. 364 (1995) 134-138.
23. I. Vermes, C. Haanen, H.S. Nakken, C. Reutlinsperger, A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein-labeled annexin V, J. Immunol. Methods 184 (1995) 39-51.
24. Y. Sato, J.-P. Daziano, F. Sieber, Photochemical purging of autologous stem cell grafts. Potentiation of the antileukemic activity of Merocyanine 540 by ethacrynic acid, Cancer Res. Ther. Contr. 5 (1998) 241-251.
25. Y. Sato, T. Yamazaki, K. Yasukawa, Y. Kaneita, J. Mochimaru, M. Hanai et al., Merocyanine 540-mediated photodynamic therapy inhibits P-glycoprotein (P-gp) activity in adriamycin-resistant K562 cells, Gan To Kagaku Ryoho 26 (1999) 2195-2200.
26. D.L. Traul, F. Sieber, Induction of apoptosis and necrosis in leukemia and solid tumor cells by merocyanine 540-mediated PDT, Photochem. Photobiol. 59 (1994) 70S.
27. F. Sieber, M. Sieber-Blum, Dye-mediated photosensitization of murine neuroblastoma cells, Cancer Res. 46 (1986) 2072-2076.
28. J. Atzpodien, S.C. Gulati, B.D. Clarkson, Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow, Cancer Res. 46 (1986) 4892-4895.
29. F. Sieber, R.K. Stuart, S.D. Rowley, S.J. Sharkis, L.L. Sensenbrenner, Dye-mediated photolysis of normal and neoplastic hematopoietic cells, Leukemia Res. 11 (1987) 43-49.
30. A. Porcellini, N. Talevi, M.T. Marchetti-Rossi, M. Palazzi, A. Manna, G. Sparaventi et al., Limiting dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540, Blood 70 (1987) 1543-1549.
31. F. Sieber, Photosensitizing agents for marrow purging in autologous bone marrow transplantation, in: N.C. Gorin, L. Douay (Eds.), Experimental Hematology Today-1989, Springer-Verlag, New York, 1990, pp. 10-15.
32. F. Sieber, Extracorporeal purging of bone marrow grafts by dye-sensitized photoirradiation, in: A.P. Gee (Ed.), Bone Marrow Processing and Purging: A Practical Guide, CRC Press, Boca Raton, 1990, pp. 263-280.
33. T.G. Easton, J.E. Valinsky, E. Reich, Merocyanine 540 as a fluorescent probe of membranes: Staining of electrically excitable cells, Cell 13 (1978) 475-486.
34. J.E. Valinsky, T.G. Easton, E. Reich, Merocyanine 540 as a fluorescent probe of membranes: Selective staining of leukemia and immature hematopoietic cells, Cell 13 (1978) 487-499.
35. B. Kalyanaraman, J.B. Feix, F. Sieber, J.P. Thomas, AW Girotti, Photodynamic action of merocyanine 540 on artificial and natural cell membranes: Involvement of singlet molecular oxygen, Proc. Natl. Acad. Sci. USA 84 (1987) 2999-3003.
36. D.K. Gaffney, S.L. Schober, F. Sieber, Merocyanine 540-sensitized photoinactivation of leukemia cells: Role of oxygen and effects on plasma membrane integrity and mitochondrial respiration, Exp. Hematol. 18 (1990) 23-26.
37. D.K. Gaffney, F. Sieber, Merocyanine 540-sensitized photoinactivation of soluble and membrane-bound enzymes in L1210 cells, Cancer Res. 50 (1990) 7765-7769.
38. O.M. Smith, D.L. Traul, F. Sieber, Photodamaging effects of Merocyanine 540 on neutrophils and HL-60 cells, Exp. Hematol. 20 (1992) 1278-1284.
39. D.L. Traul, O.M. Smith, F. Sieber, Effects of merocyanine 540-sensitized photoirradiation on cation homeostasis in L1210 leukemia and A549 lung carcinoma cells, Exp. Hematol. 20 (1992) 730.
40. F. Sieber, J. Hilton, O.M. Colvin, Photodynamic therapy of drug-resistant tumors, Exp. Hematol. 12 (1984) 423.
41. D.K. Gaffney, J.M. O'Brien, F. Sieber, Modulation by thiols of the Merocyanine 540-sensitized photolysis of leukemia cells, red cells, and Herpes simplex virus type I, Photochem. Photobiol. 53 (1991) 85-92.
42. T. Yamazaki, Y. Sato, F. Sieber, Role of cytoprotective mechanisms in the photochemical purging of autologous bone marrow grafts, Exp. Hematol. 25 (1997) 629-637.
43. J.M. O'Brien, F. Sieber, Mutagenicity of merocyanine 540-mediated photosensitization, Exp. Hematol. 17 (1989) 166-170.
44. G.S. Anderson, W.H.H. Günther, R. Searle, J.M. Bilitz, M. Krieg, F. Sieber, Inactivation of photosensitizing merocyanine dyes by plasma, serum, and serum components, Photochem. Photobiol. 64 (1996) 683-687.
45. I. Tsujino, G.S. Anderson, F. Sieber, Postirradiation hyperthermia selectively potentiates the Merocyanine 540-sensitized photoinactivation of small cell lung cancer cells, Photochem. Photobiol. 73 (2001) 191-198.
46. D.E. Levin, T.J. Lovely, E. Klekowski, Light-enhanced genetic toxicity of crystal violet, Mutat. Res. 103 (1982) 283-288.
47. S.M. Thomas, D.G. MacPhee, Crystal violet: a direct-acting frameshift mutagen whose mutagenicity is enhanced by mammalian metabolism, Mutat. Res. 140 (1984) 165-167.
48. A. Aidoo, N. Gao, R.E. Neft, H.M. Schol, B.S. Hass, TY Minor, R.H. Heflich, Evaluation of the genotoxicity of gentian violet in bacterial and mammalian systems, Teratog. Carcinog. Mutagen. 10 (1990) 449-462.
49. J. Morgan, J.E. Whitaker, A.R. Oseroff, GRP78 induction by calcium ionophore potentiates photodynamic therapy using the mitochondrial targeting dye Victoria Blue BO, Photochem. Photobiol. 67 (1998) 155-164.
50. F. Sieber, D.K. Gaffney, J.M. O'Brien, W.S. Sprague, O.M. Smith, K. Qiu et al., Cellular defense mechanisms against merocyanine 540-mediated photodynamic damages, Exp. Hematol. 19 (1991) 565.
51. S. Davis, M.J. Weiss, J.R. Wing, T.J. Lampidis, L.B. Chen, Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells, J. Biol. Chem. 260 (1985) 13844-13850.
52. I.K. Kandela, J.A. Bartlett, G.L. Indig, Effect of molecular structure on the selective phototoxicity of triarylmethane dyes towards tumor cells, Photochem. Photobiol. Sci. 1 (2002) 309-314.
53. American Type Culture Collection, On-Line Cell Biology Collection Catalog, information on CV-1 (CCL-70) cells.
54. D. Brouty-Boye, D. Kolonias, C.J. Wu, N. Saravaj, T.J. Lampidis, Relationship of multidrug resistance to rhodamine-123 selectivity between carcinoma and normal epithelial cells: taxol and vinblastine modulate drug efflux, Cancer Res. 55 (1995) 1633-1638.
55. H. Tapiero, J.-C. Munck, A. Fourcade, T.J. Lampidis, Cross-resistance to rhodamine 123 in Adriamycin- and daunorubicin-resistant Friend leukemia cell variants, Cancer Res. 44 (1984) 5544-5549.
56. M.A. Valverde, M. Diaz, F.V. Sepulveda, D.R. Gill, S.C. Hyde, C.F. Higgins, Volume-regulated chloride channels associated with the human multi-drug resistance P-glycoprotein, Nature 355 (1992) 830-833.
57. P.M. Chaudhary, I.B. Roninson, Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells, Cell 66 (1991) 85-94.